BPA Call 36E79722A0025-36C24826N0054
Award Date
10/1/25
Potential Completion Date
9/30/26
Potential Value
$1.8M
Federal Agency
Veterans Integrated Service Network 8
Awardee
Telix Pharmaceuticals US Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fishers, IN 46037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) through its Veterans Health Administration (VHA). The contract, with a ceiling value of $858,000.00, is for the delivery of various radiopharmaceuticals to support the VA's nuclear medicine and medical imaging services for veterans. The contract is a Blanket Purchase Agreement (BPA) call order awarded under a larger $17.5 million BPA the company...
This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract, valued at $1,815,000.00, is a Blanket Purchase Agreement (BPA) call order for the radiopharmaceutical product Illuccix. Illuccix is used for nuclear medicine and medical imaging services, with a focus on oncology applications. The contract has an ultimate completion date of September 30, 2025 and is a firm fixed-price arrangement....
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a for-profit manufacturer of goods. The $161,700 contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities through February 2025. This award is part of a larger $17.5 million Blanket Purchase Agreement (BPA) the VA awarded Telix in...
This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with a ceiling value of $165,000.00. The contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities across the country. This award is part of Telix's broader contract vehicles with the VA, which include...
This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) in the amount of $334,300.00. The award is for the delivery of Illuccix, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine and medical imaging services. The award was issued under Telix's existing $17.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, as well as the company's other contract...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures,...
Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc. The contract has a ceiling value of $432,300.00 and an ultimate completion date of February 11, 2026. It is for the supply of ILLUCCIX PSMA VASD, a radiopharmaceutical product used for nuclear medicine and medical imaging services. The contract is not set aside and is part of Telix Pharmaceuticals' existing Federal Supply Schedule (FSS) contracts under...
Telix Pharmaceuticals US Inc. was awarded a $245,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The one-year contract calls for the prime contractor to provide Gozetotide Radiopharmaceuticals to the agency. Telix Pharmaceuticals will perform the work in Norcross, Georgia, providing the specified radiopharmaceutical products to support the...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $665,200 firm fixed price delivery order contract to Telix Pharmaceuticals US Inc. to provide ILLUCCIX (MEDICATION) ORDER. The contract has a period of performance from July 11, 2022 through October 31, 2022 and will be performed at the VETERANS ADMINISTRATION facility located in West Los Angeles, California.</p>